Wells Fargo & Company Capricor Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 44,946 shares of CAPR stock, worth $973,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,946

Previous 32,562 38.03%

Holding current value

$973,080

Previous $221,000 3.17%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.63 - $7.09 $57,337 - $87,802	12,384 Added 38.03%	44,946 $214,000
Q1 2024 May 10, 2024	BUY	$3.61 - $6.88 $116,696 - $222,402	32,326 Added 13697.46%	32,562 $221,000
Q4 2023 Feb 09, 2024	BUY	$2.71 - $5.08 $130 - $243	48 Added 25.53%	236 $1,000
Q3 2023 Nov 13, 2023	SELL	$3.42 - $7.85 $3,399 - $7,802	-994 Reduced 84.09%	188 $0
Q2 2023 Aug 15, 2023	BUY	$3.76 - $5.05 $26 - $35	7 Added 0.6%	1,182 $5,000
Q1 2023 May 12, 2023	BUY	$3.78 - $5.03 $3,791 - $5,045	1,003 Added 583.14%	1,175 $4,000
Q4 2022 Feb 13, 2023	BUY	$3.36 - $6.55 $33 - $65	10 Added 6.17%	172 $0
Q3 2022 Nov 14, 2022	SELL	$3.61 - $6.08 $3 - $6	-1 Reduced 0.61%	162 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.89 - $4.51 $2,849 - $4,446	-986 Reduced 85.81%	163 $1,000
Q1 2022 May 16, 2022	BUY	$2.83 - $5.68 $2 - $5	1 Added 0.09%	1,149 $4,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.16 $2,913 - $4,193	1,008 Added 720.0%	1,148 $3,000
Q3 2021 Nov 15, 2021	SELL	$3.8 - $5.23 $26 - $36	-7 Reduced 4.76%	140 $1,000
Q2 2021 Aug 16, 2021	BUY	$3.16 - $5.72 $44 - $80	14 Added 10.53%	147 $1,000
Q4 2020 Feb 09, 2021	BUY	$3.43 - $5.23 $41 - $62	12 Added 9.92%	133 $0
Q3 2020 Nov 05, 2020	SELL	$4.08 - $9.81 $11,840 - $28,468	-2,902 Reduced 96.0%	121 $1,000
Q2 2020 Aug 13, 2020	BUY	$1.0 - $8.5 $3,000 - $25,500	3,000 Added 13043.48%	3,023 $14,000
Q1 2020 May 14, 2020	BUY	$0.94 - $2.02 $21 - $46	23 New	23 $0

Others Institutions Holding CAPR

# of Institutions

Shares Held

6.34M

Call Options Held

210K

Put Options Held

374K

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $527M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Capricor Therapeutics, Inc. Transaction History